Markers of coagulation and inflammation and adverse events in patients with active cancer and atherosclerosis: common features and differences
Introduction. Thrombotic complications (TC) in different vascular systems dictate the fate of high-risk patients. In cardiological practice, patients with advanced atherosclerotic vascular disease (MFA) represent the most vulnerable group. Malignant neoplasm (MN) is one of the most significant risk...
المؤلفون الرئيسيون: | Yu. A. Fedotkina, A. L. Komarov, А. В. Dobrovolsky, E. N. Krivosheeva, О. О. Frolkova, E. V. Titaeva, T. V. Balakhonova, Е. Р. Panchenko |
---|---|
التنسيق: | مقال |
اللغة: | Russian |
منشور في: |
«REMEDIUM GROUP» Ltd.
2023-01-01
|
سلاسل: | Атеротромбоз |
الموضوعات: | |
الوصول للمادة أونلاين: | https://www.aterotromboz.ru/jour/article/view/287 |
مواد مشابهة
-
GDF-15 and the risk of bleeding in patients with stable CAD receiving multicomponent antithrombotic therapy: the results of the prospective REGATA register
حسب: Elena N. Krivosheeva, وآخرون
منشور في: (2024-07-01) -
Growth differentiation factor 15 and the risk of cardiovascular events in patients with atrial fibrillation after elective percutaneous coronary intervention
حسب: E. N. Krivosheeva, وآخرون
منشور في: (2021-08-01) -
Serum Concentration of Growth Differentiation Factor 15 and Atherosclerosis among General Older Japanese Individuals with Normal Weight
حسب: Yuji Shimizu, وآخرون
منشور في: (2023-05-01) -
Assessment of the Anticancer Effects of Simvastatin on Human Osteosarcoma and Colorectal Cancer Cell Lines
حسب: Sarah Mazin Naeem, وآخرون
منشور في: (2024-12-01) -
Relationship between lipid profile parameters, coagulation system and inflammation markers in patients with hypertension and multifocal atherosclerosis
حسب: S. S. Vedenskaya, وآخرون
منشور في: (2024-12-01)